Fortfahren mit
Größe auswählen
| Ihnen/SKU | Verfügbarkeit | Preis |
|---|---|---|
20 mg | Warenkorb auf Verfügbarkeit prüfen | € 1.270,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
doxazosin
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
[Cl-].[N+H2]1CCN(CC1)C(=O)C2Oc3c(cccc3)OC2
InChI
1S/C13H16N2O3.ClH/c16-13(15-7-5-14-6-8-15)12-9-17-10-3-1-2-4-11(10)18-12;/h1-4,12,14H,5-9H2;1H
InChI key
TUKBWYXLYINULI-UHFFFAOYSA-N
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
- Doxazosin Mesylate
- Doxazosin Tablets
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| manufacturer/tradename USP | manufacturer/tradename - | manufacturer/tradename - | manufacturer/tradename - |
| grade pharmaceutical primary standard | grade certified reference material, pharmaceutical secondary standard | grade certified reference material, pharmaceutical secondary standard | grade certified reference material, pharmaceutical secondary standard |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical | application(s) pharmaceutical | application(s) pharmaceutical |
| format neat | format - | format - | format - |
| API family doxazosin | API family - | API family - | API family - |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. - |
Still not finding the right product?
Explore all of our products under Doxazosin-verwandte Verbindung A
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Chronic 2 - STOT RE 2
Lagerklasse
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.






